| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-11 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |